Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial Pavel, M., Benavent, M., Perros, P., Srirajaskanthan, R., Warner, R. P., Kulke, M. H., Anthony, L. B., Kunz, P. L., Hoersch, D., Lapuerta, P., Fleming, R., Gross, D. J. LIPPINCOTT WILLIAMS & WILKINS. 2018: 350

View details for Web of Science ID 000426086300085